Protocolo de interpretación clínicade los hallazgos ecocardiográficos

  1. Martínez Monzonís, Amparo
  2. Abu Assi, Emad
  3. Raposeiras Roubín, Sergio
  4. Vega Fernández, J. M.
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Año de publicación: 2013

Serie: 11

Número: 41

Páginas: 2479-2482

Tipo: Artículo

DOI: 10.1016/S0304-5412(13)70648-6 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Medicine: Programa de Formación Médica Continuada Acreditado

Objetivos de desarrollo sostenible

Resumen

Patients with symptomatic valvular heart disease have a low life expectancy. Surgical or percutaneous treatment, depending on the type of valvulopathy, improves life expectancy, patient prognosis and quality of life. To identify optimal timing of surgery is important. As it has been recommended by different guidelines for the management of patients with valvular heart disease, the occurrence of symptoms will determine the timing. As it is described in the Euro Heart Survey on valvular heart disease, in recent decades the incidence of valvulopathies among the elderly has been increasing. In the elderly patients, clinical assessment is difficult for two reasons: patients� tendency to downplay the symptomatology and the high comorbidities associated that may mimic symptoms of other heart diseases. In addition to clinical findings, echocardiography is the key technique to confirm the diagnosis of valvular heart disease and should include a comprehensive evaluation of all valves, looking for associated valve diseases and its symptomatology. The most appropriate echocardiographic technique to each type of valvular heart disease should be known, as well.

Referencias bibliográficas

  • Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22(1):1-23.
  • Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD. 2008 Focused update incorporated into the ACC/AHA 2006 gguidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society and Interventions, and Society of Thoracic Surgeons of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography. Circulation. 2008;118:e523-661.
  • Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J. 2003;24:1231-43.
  • Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013;14(7):611-44.
  • Maréchaux S, Hachicha Z, Bellouin A, Dumesnil JG, Meimoun P, Pasquet A. Usefulnes of exercise estress echocardiography for risk stratification of true asyntomatic patients with aortic valve stenosis. Eur Herat J. 2010;31:1390-7.
  • Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Sarano ME. Burden of valvular heart diseases. A population based study. Lancet. 2006;368:1005-11.
  • Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451-96.
  • Zamorano JL, Gonzalves A. Exercise echocardiography in aortic stenosis. One more piece in the puzzle. Eur Heart J. 2010;31:1295-7.
Fuente de los datos: Dialnet